26B-4-212. Institutional review board -- Approved study of cannabis, a cannabinoid product, or an expanded cannabinoid product.

305 words·~1 min read·/ut/title-26b/chapter-4/26b-4-212

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Effective 5/6/2026

(1)As used in this section:

(a)"Approved study" means a medical research study:

(i)the purpose of which is to investigate the medical benefits and risks of cannabinoid products; and

(ii)that is approved by an IRB.

(b)"Cannabinoid product" means the same as that term is defined in Section 58-37-403 .

(c)"Cannabis" means the same as that term is defined in Section 58-37-403 .

(d)"Expanded cannabinoid product" means the same as that term is defined in Section 58-37-403 .

(e)"Institutional review board" or "IRB" means an institutional review board that is registered for human subject research by the United States Department of Health and Human Services.

(2)A person conducting an approved study may, for the purposes of the study:

(a)process a cannabinoid product or an expanded cannabinoid product;

(b)possess a cannabinoid product or an expanded cannabinoid product; and

(c)administer a cannabinoid product, or an expanded cannabinoid product to an individual in accordance with the approved study.

(3)A person conducting an approved study may:

(a)import cannabis, a cannabinoid product, or an expanded cannabinoid product from another state if:

(i)the importation complies with federal law; and

(ii)the person uses the cannabis, cannabinoid product, or expanded cannabinoid product in accordance with the approved study; or

(b)obtain cannabis, a cannabinoid product, or an expanded cannabinoid product from the National Institute on Drug Abuse.

(4)A person conducting an approved study may distribute cannabis, a cannabinoid product, or an expanded cannabinoid product outside the state if:

(a)the distribution complies with federal law; and

(b)the distribution is for the purposes of, and in accordance with, the approved study.

Amended by Chapter 362 , 2026 General Session